Summary
GlobalData's Partnerships,
Licensing, Investments and M&A Deals and Trends for January 2014 in
Pharmaceuticals report is an essential source of data and trend analysis on
partnerships, licensing, mergers and acquisitions (M&As) and financings in the
pharmaceuticals industry. The report provides detailed information on
partnership and licensing transactions, M&As, equity/debt offerings,
private equity, and venture financing registered in the pharmaceuticals
industry in July 2013. The report portrays detailed comparative data on the
number of deals and their value in the last six months, subdivided by deal
types, various therapy areas, and geographies. Additionally, the report
provides information on the top financial advisory firms in the pharmaceuticals
industry.
Data presented in this report is
derived from GlobalDatas proprietary in-house deals database and primary and
secondary research.
Scope
* Analysis of the market trends for
the pharmaceutical industry in the global arena.
* Review of deal trends in the
cardiovascular, central nervous system, dermatology, ear nose throat disorders,
gastrointestinal, genito urinary system and sex hormones, hematological
disorders, hormonal disorders, immunology, infectious disease, male health,
metabolic disorders, mouth and dental disorders, musculoskeletal, oncology,
ophthalmology, respiratory, toxicology, and women's health segments.
* Analysis of partnerships,
licensing, M&As, equity/debt offerings, private equity, and venture
financing deals in the pharmaceutical industry.
* Analysis of therapy areas which
are very active in terms of venture capital financing, partnerships, licensing
agreements, equity/debt offerings, and M&As.
* Analysis of deals based on
different payment modes, including upfront and milestone payments, primarily in
partnerships and licensing agreements in the pharmaceutical industry.
* Analysis of partnership and
licensing deals based on clinical stage of development of products.
* Summary of the pharmaceutical
deals globally in the six months.
* Information on the top deals
happened in the pharmaceutical industry.
* Geographies covered include -
North America, Europe, Asia Pacific, South & Central America, and the
Middle East & Africa.
* League tables of financial
advisors in M&As and equity/debt offerings. This includes key advisors such
as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
* Enhance your decision making
capability in a more rapid and time sensitive manner.
* Find out the major deal performing
segments for investments in your industry.
* Evaluate the types of companies
which are entering into partnership or licensing agreements; divesting and
acquiring assets.
* Identify companies that are
aggressively looking to raise capital in the market
* Evaluate niche therapy areas that
are receiving majority of the upfront and milestone payments in the
pharmaceutical industry.
* Identify the key venture
capitalists, who are financing the pharmaceutical and biotech companies.
* Evaluate the clinical development stages
where majority of the partnerships and licensing agreements are happening.
* Do deals with an understanding of
how competitors are financed, and the mergers and partnerships that have shaped
the pharmaceutical industry.
* Identify growth segments and
opportunities in each region within the industry.
* Look for key financial advisors
where you are planning to raise capital from the market or for acquisitions
within the industry.
To order this report:
Email: customerservice@researchonglobalmarkets.com
US:
+1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.com
RELATED LINK:
